VTYX VENTYX BIOSCIENCES INC revenue, earnings and financials
For the quarter ended September 30, 2025, VENTYX BIOSCIENCES INC reported revenue of n/a, net income of −$22.8M and diluted EPS of −$0.32; for the fiscal year ended December 2024 revenue was n/a.
VTYX annual revenue and earnings
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income −$148M, net income −$135M (margin n/a), EPS −$1.97
- Fiscal year ended Dec 2023: revenue n/a, gross profit n/a, operating income −$208M, net income −$193M (margin n/a), EPS −$3.30
- Fiscal year ended Dec 2022: revenue n/a, gross profit n/a, operating income −$113M, net income −$108M (margin n/a), EPS −$2.07
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$67.1M, net income −$83.7M (margin n/a), EPS −$6.65
VTYX quarterly revenue and earnings
- Quarter ended Sep 30, 2025: revenue n/a, net income −$22.8M, EPS −$0.32
- Quarter ended Jun 30, 2025: revenue n/a, net income −$27.0M, EPS −$0.38
- Quarter ended Mar 31, 2025: revenue n/a, net income −$27.4M, EPS −$0.39
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$29.4M, EPS −$0.35
- Quarter ended Sep 30, 2024: revenue n/a, net income −$35.2M, EPS −$0.50
- Quarter ended Jun 30, 2024: revenue n/a, net income −$32.0M, EPS −$0.50
- Quarter ended Mar 31, 2024: revenue n/a, net income −$38.6M, EPS −$0.62
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$46.8M, EPS −$0.79
- Quarter ended Sep 30, 2023: revenue n/a, net income −$54.0M, EPS −$0.92
- Quarter ended Jun 30, 2023: revenue n/a, net income −$53.3M, EPS −$0.91
- Quarter ended Mar 31, 2023: revenue n/a, net income −$38.9M, EPS −$0.68
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$35.2M, EPS −$0.64
- Quarter ended Sep 30, 2022: revenue n/a, net income −$30.5M, EPS −$0.59
- Quarter ended Jun 30, 2022: revenue n/a, net income −$20.0M, EPS −$0.39
- Quarter ended Mar 31, 2022: revenue n/a, net income −$22.7M, EPS −$0.45
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$17.8M, EPS $16.05
- Quarter ended Sep 30, 2021: revenue n/a, net income −$12.8M, EPS −$3.17
- Quarter ended Jun 30, 2021: revenue n/a, net income −$15.6M, EPS −$4.31
- Quarter ended Mar 31, 2021: revenue n/a, net income −$37.6M, EPS −$15.22
VTYX cash flow, buybacks and dividends
- Fiscal year ended Dec 2024: operating cash flow −$131M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$167M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$98.8M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$38.7M, share buybacks n/a
VTYX balance sheet
- Sep 30, 2025: cash $32.0M, total assets $211M, total liabilities $20.1M, shareholders' equity $191M
- Jun 30, 2025: cash $32.3M, total assets $230M, total liabilities $20.6M, shareholders' equity $209M
- Mar 31, 2025: cash $28.1M, total assets $253M, total liabilities $21.8M, shareholders' equity $232M
- Dec 31, 2024: cash $27.3M, total assets $277M, total liabilities $22.5M, shareholders' equity $254M
- Sep 30, 2024: cash $61.8M, total assets $301M, total liabilities $22.3M, shareholders' equity $279M
- Jun 30, 2024: cash $40.9M, total assets $309M, total liabilities $28.4M, shareholders' equity $281M
- Mar 31, 2024: cash $142M, total assets $332M, total liabilities $25.1M, shareholders' equity $307M
- Dec 31, 2023: cash $51.6M, total assets $278M, total liabilities $33.8M, shareholders' equity $244M
Is VTYX profitable?
No. VENTYX BIOSCIENCES INC lost $107M over the last four quarters.
What is VTYX's EPS?
Diluted earnings per share over the last four quarters were −$1.44; −$0.32 in the latest quarter.